Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.905 USD | +1.76% | -4.36% | -24.73% |
May. 08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
May. 08 | Transcript : Zevra Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 29.36M | Sales 2025 * | 95.29M | Capitalization | 202M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | -13M | EV / Sales 2024 * | 6.87 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.12 x |
P/E ratio 2024 * |
-3.18
x | P/E ratio 2025 * |
-11.1
x | Employees | 67 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.28% |
Latest transcript on Zevra Therapeutics, Inc.
1 day | -4.17% | ||
1 week | +0.21% | ||
Current month | +5.24% | ||
1 month | +0.42% | ||
3 months | -21.11% | ||
6 months | +16.14% | ||
Current year | -26.41% |
Managers | Title | Age | Since |
---|---|---|---|
Christal Mickle
FOU | Founder | 45 | 06-10-29 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 23-10-09 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 15-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 23-04-24 |
Tamara Favorito
CHM | Chairman | 65 | 21-08-17 |
Director/Board Member | 56 | 23-04-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 4.93 | +2.28% | 96 715 |
24-05-10 | 4.82 | -4.17% | 250,744 |
24-05-09 | 5.03 | -2.52% | 190,174 |
24-05-08 | 5.16 | -0.29% | 229,449 |
24-05-07 | 5.175 | +0.39% | 305,903 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.41% | 202M | |
+8.05% | 72.81B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
+18.14% | 2.42B | |
-26.13% | 2.32B | |
+19.31% | 2.17B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ZVRA Stock